Novartis to Acquire Xiidra
Friday, May 10 2019 | 12 h 12 min | Acquisitions, News, Press Release
Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with...
Read More
Novartis, Alcon Report Growth In Second Quarter of 2018
Tuesday, July 24 2018 | 09 h 56 min | Financial News, News
Both Novartis and Alcon reported that their net sales grew by 5%, while Alcon’s core operating income grew 14% Alcon’s net sales were USD 18...
Read More Novartis Announces Intention to Spin Off Alcon
Friday, June 29 2018 | 11 h 33 min | News
Novartis has announced that they intend to seek shareholder approval to spin off 100% of Alcon's eye care device business into a standalone,...
Read More Novartis Delivers Strong First Quarter in 2018
Friday, April 20 2018 | 12 h 32 min | Financial News, News, Press Release
Net sales for the first quarter of 2018 were CAD 161 billion, an increase of 4% at constant currencies Core operating income also grew by...
Read More Novartis CEO Joseph Jimenez to Retire in 2018
Wednesday, September 6 2017 | 00 h 00 min | News, Press Release
Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire to step down as CEO in 2018, after eight...
Read More
